SonaCare Medical

Is mpMRI the Key to Making Smarter Use of Ablative Technologies?

By Sonacare Medical Published: April 03, 2018, 01:00 PM

Focal therapies for cancer have been around for more than two decades and have been accepted treatment options for breast and renal cancers. Gaining acceptance for prostate cancer, however, has been a long-winding road.

Read More

Making Efficient Use of mpMRI Data

By Sonacare Medical Published: March 27, 2018, 01:00 PM

With the growing acceptance of the value of multi-parametric MRI (mpMRI) the detection, diagnosis and treatment of prostate cancer is undergoing a paradigm shift away from biomarkers and standard 12-core biopsies to imaging-based strategies with targeted biopsies.

Read More

Has MRI-Based Diagnosis for Prostate Cancer Overtaken TRUS Biopsy?

By Sonacare Medical Published: March 20, 2018, 03:00 PM

Since the US Preventive Services Task Force (USPSTF) gave prostate cancer screening a “D” grade in 2012, researchers have been looking for better ways to detect, diagnose and treat prostate cancer. Blood tests such as the PSA and imaging and biopsy tests, however, have lacked specificity, identifying cancer only about half the time, while missing clinically significant cancer.

Read More

What is a C-Code and how does it affect HIFU procedure reimbursement?

By Sonacare Medical Published: November 07, 2017, 09:22 AM

What is a C-code?

According to the Centers for Medicare and Medicaid Services (CMS) Healthcare Common Procedure Coding System (HCPCS) or “C-codes” are unique temporary pricing codes established for the Prospective Payment System and are only valid for Medicare on claims for hospital outpatient department services and procedures.

Read More